Last 12 months
Inside the activity.
33 purchase rows · 0 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 32 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 1 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 02, 2016 Filed Sep 6, 2016 15:00 UTC |
FROST PHILLIP MD ET ALDirector · CEO & Chairman · 10% owner
Frost Gamma Investments Trust10% owner
|
PurchaseCommon Stock | 3,000 | $9.34 | $28,020.00 |
DisclosureSEC source: 0001209191-16-139955 · doc4.xml · nonDerivative · entry 9 FROST PHILLIP MD ET AL · CIK 0000898860 · Director · CEO & Chairman · 10% owner Frost Gamma Investments Trust · CIK 0001380896 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 160,121,543 F1 · ownership.nature: The securities are held by Frost Gamma Investments Trust, of which Phillip Frost M.D., is the trustee. Frost Gamma L.P. is the sole and exclusive beneficiary of Frost Gamma Investments Trust. Dr. Frost is one of two limited partners of Frost Gamma L.P. The general partner of Frost Gamma L.P. is Frost Gamma, Inc., and the sole shareholder of Frost Gamma, Inc. is Frost-Nevada Corporation. Dr. Frost is also the sole shareholder of Frost-Nevada Corporation. The reporting person disclaims beneficial ownership of these securities, except to the extent of any pecuniary interest therein and this report shall not be deemed an admission that the reporting person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. Read SEC document |
| September 02, 2016 Filed Sep 6, 2016 15:00 UTC |
FROST PHILLIP MD ET ALDirector · CEO & Chairman · 10% owner
Frost Gamma Investments Trust10% owner
|
PurchaseCommon Stock | 1,000 | $9.33 | $9,330.00 |
DisclosureSEC source: 0001209191-16-139955 · doc4.xml · nonDerivative · entry 8 FROST PHILLIP MD ET AL · CIK 0000898860 · Director · CEO & Chairman · 10% owner Frost Gamma Investments Trust · CIK 0001380896 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 160,118,543 F1 · ownership.nature: The securities are held by Frost Gamma Investments Trust, of which Phillip Frost M.D., is the trustee. Frost Gamma L.P. is the sole and exclusive beneficiary of Frost Gamma Investments Trust. Dr. Frost is one of two limited partners of Frost Gamma L.P. The general partner of Frost Gamma L.P. is Frost Gamma, Inc., and the sole shareholder of Frost Gamma, Inc. is Frost-Nevada Corporation. Dr. Frost is also the sole shareholder of Frost-Nevada Corporation. The reporting person disclaims beneficial ownership of these securities, except to the extent of any pecuniary interest therein and this report shall not be deemed an admission that the reporting person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. Read SEC document |
| September 02, 2016 Filed Sep 6, 2016 15:00 UTC |
FROST PHILLIP MD ET ALDirector · CEO & Chairman · 10% owner
Frost Gamma Investments Trust10% owner
|
PurchaseCommon Stock | 1,000 | $9.31 | $9,310.00 |
DisclosureSEC source: 0001209191-16-139955 · doc4.xml · nonDerivative · entry 7 FROST PHILLIP MD ET AL · CIK 0000898860 · Director · CEO & Chairman · 10% owner Frost Gamma Investments Trust · CIK 0001380896 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 160,117,543 F1 · ownership.nature: The securities are held by Frost Gamma Investments Trust, of which Phillip Frost M.D., is the trustee. Frost Gamma L.P. is the sole and exclusive beneficiary of Frost Gamma Investments Trust. Dr. Frost is one of two limited partners of Frost Gamma L.P. The general partner of Frost Gamma L.P. is Frost Gamma, Inc., and the sole shareholder of Frost Gamma, Inc. is Frost-Nevada Corporation. Dr. Frost is also the sole shareholder of Frost-Nevada Corporation. The reporting person disclaims beneficial ownership of these securities, except to the extent of any pecuniary interest therein and this report shall not be deemed an admission that the reporting person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. Read SEC document |
| September 02, 2016 Filed Sep 6, 2016 15:00 UTC |
FROST PHILLIP MD ET ALDirector · CEO & Chairman · 10% owner
Frost Gamma Investments Trust10% owner
|
PurchaseCommon Stock | 1,000 | $9.28 | $9,280.00 |
DisclosureSEC source: 0001209191-16-139955 · doc4.xml · nonDerivative · entry 6 FROST PHILLIP MD ET AL · CIK 0000898860 · Director · CEO & Chairman · 10% owner Frost Gamma Investments Trust · CIK 0001380896 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 160,116,543 F1 · ownership.nature: The securities are held by Frost Gamma Investments Trust, of which Phillip Frost M.D., is the trustee. Frost Gamma L.P. is the sole and exclusive beneficiary of Frost Gamma Investments Trust. Dr. Frost is one of two limited partners of Frost Gamma L.P. The general partner of Frost Gamma L.P. is Frost Gamma, Inc., and the sole shareholder of Frost Gamma, Inc. is Frost-Nevada Corporation. Dr. Frost is also the sole shareholder of Frost-Nevada Corporation. The reporting person disclaims beneficial ownership of these securities, except to the extent of any pecuniary interest therein and this report shall not be deemed an admission that the reporting person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. Read SEC document |
| September 02, 2016 Filed Sep 6, 2016 15:00 UTC |
FROST PHILLIP MD ET ALDirector · CEO & Chairman · 10% owner
Frost Gamma Investments Trust10% owner
|
PurchaseCommon Stock | 1,000 | $9.26 | $9,260.00 |
DisclosureSEC source: 0001209191-16-139955 · doc4.xml · nonDerivative · entry 5 FROST PHILLIP MD ET AL · CIK 0000898860 · Director · CEO & Chairman · 10% owner Frost Gamma Investments Trust · CIK 0001380896 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 160,115,543 F1 · ownership.nature: The securities are held by Frost Gamma Investments Trust, of which Phillip Frost M.D., is the trustee. Frost Gamma L.P. is the sole and exclusive beneficiary of Frost Gamma Investments Trust. Dr. Frost is one of two limited partners of Frost Gamma L.P. The general partner of Frost Gamma L.P. is Frost Gamma, Inc., and the sole shareholder of Frost Gamma, Inc. is Frost-Nevada Corporation. Dr. Frost is also the sole shareholder of Frost-Nevada Corporation. The reporting person disclaims beneficial ownership of these securities, except to the extent of any pecuniary interest therein and this report shall not be deemed an admission that the reporting person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. Read SEC document |
| September 02, 2016 Filed Sep 6, 2016 15:00 UTC |
FROST PHILLIP MD ET ALDirector · CEO & Chairman · 10% owner
Frost Gamma Investments Trust10% owner
|
PurchaseCommon Stock | 1,000 | $9.22 | $9,220.00 |
DisclosureSEC source: 0001209191-16-139955 · doc4.xml · nonDerivative · entry 4 FROST PHILLIP MD ET AL · CIK 0000898860 · Director · CEO & Chairman · 10% owner Frost Gamma Investments Trust · CIK 0001380896 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 160,114,543 F1 · ownership.nature: The securities are held by Frost Gamma Investments Trust, of which Phillip Frost M.D., is the trustee. Frost Gamma L.P. is the sole and exclusive beneficiary of Frost Gamma Investments Trust. Dr. Frost is one of two limited partners of Frost Gamma L.P. The general partner of Frost Gamma L.P. is Frost Gamma, Inc., and the sole shareholder of Frost Gamma, Inc. is Frost-Nevada Corporation. Dr. Frost is also the sole shareholder of Frost-Nevada Corporation. The reporting person disclaims beneficial ownership of these securities, except to the extent of any pecuniary interest therein and this report shall not be deemed an admission that the reporting person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. Read SEC document |
| September 02, 2016 Filed Sep 6, 2016 15:00 UTC |
FROST PHILLIP MD ET ALDirector · CEO & Chairman · 10% owner
Frost Gamma Investments Trust10% owner
|
PurchaseCommon Stock | 1,000 | $9.20 | $9,200.00 |
DisclosureSEC source: 0001209191-16-139955 · doc4.xml · nonDerivative · entry 3 FROST PHILLIP MD ET AL · CIK 0000898860 · Director · CEO & Chairman · 10% owner Frost Gamma Investments Trust · CIK 0001380896 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 160,113,543 F1 · ownership.nature: The securities are held by Frost Gamma Investments Trust, of which Phillip Frost M.D., is the trustee. Frost Gamma L.P. is the sole and exclusive beneficiary of Frost Gamma Investments Trust. Dr. Frost is one of two limited partners of Frost Gamma L.P. The general partner of Frost Gamma L.P. is Frost Gamma, Inc., and the sole shareholder of Frost Gamma, Inc. is Frost-Nevada Corporation. Dr. Frost is also the sole shareholder of Frost-Nevada Corporation. The reporting person disclaims beneficial ownership of these securities, except to the extent of any pecuniary interest therein and this report shall not be deemed an admission that the reporting person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. Read SEC document |
| September 02, 2016 Filed Sep 6, 2016 15:00 UTC |
FROST PHILLIP MD ET ALDirector · CEO & Chairman · 10% owner
Frost Gamma Investments Trust10% owner
|
PurchaseCommon Stock | 1,000 | $9.18 | $9,180.00 |
DisclosureSEC source: 0001209191-16-139955 · doc4.xml · nonDerivative · entry 2 FROST PHILLIP MD ET AL · CIK 0000898860 · Director · CEO & Chairman · 10% owner Frost Gamma Investments Trust · CIK 0001380896 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 160,112,543 F1 · ownership.nature: The securities are held by Frost Gamma Investments Trust, of which Phillip Frost M.D., is the trustee. Frost Gamma L.P. is the sole and exclusive beneficiary of Frost Gamma Investments Trust. Dr. Frost is one of two limited partners of Frost Gamma L.P. The general partner of Frost Gamma L.P. is Frost Gamma, Inc., and the sole shareholder of Frost Gamma, Inc. is Frost-Nevada Corporation. Dr. Frost is also the sole shareholder of Frost-Nevada Corporation. The reporting person disclaims beneficial ownership of these securities, except to the extent of any pecuniary interest therein and this report shall not be deemed an admission that the reporting person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. Read SEC document |
| February 05, 2016 Filed Mar 12, 2019 20:26 UTC |
Yu Alice Lin-TsingDirector
|
GiftCommon Stock | 13,270 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-018802 · doc5.xml · nonDerivative · entry 2 Yu Alice Lin-Tsing · CIK 0001462564 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 79,950 Read SEC document |
| July 10, 2015 Filed Mar 12, 2019 20:26 UTC |
Yu Alice Lin-TsingDirector
|
GiftCommon Stock | 6,780 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-018802 · doc5.xml · nonDerivative · entry 1 Yu Alice Lin-Tsing · CIK 0001462564 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 93,220 Read SEC document |
| April 15, 2014 Filed Mar 15, 2017 22:30 UTC |
LERNER RICHARD ADirector
|
GiftCommon Stock | 31,872 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-020902 · doc5.xml · nonDerivative · entry 4 LERNER RICHARD A · CIK 0001316274 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 105,749 Read SEC document |
| April 15, 2014 Filed Mar 15, 2017 22:30 UTC |
LERNER RICHARD ADirector
|
GiftCommon Stock | 31,872 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-020902 · doc5.xml · nonDerivative · entry 3 LERNER RICHARD A · CIK 0001316274 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,000 Read SEC document |
| January 31, 2014 Filed Feb 5, 2019 21:31 UTC |
HSIAO JANE PH DDirector · Vice Chairman & CTO
|
PurchaseCommon Stock | 10,000 | $7.96 | $79,600.00 |
DisclosureSEC source: 0001209191-19-007347 · doc4.xml · nonDerivative · entry 2 HSIAO JANE PH D · CIK 0001188834 · Director · Vice Chairman & CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,465,147 Read SEC document |
| January 16, 2014 Filed Mar 15, 2017 22:30 UTC |
LERNER RICHARD ADirector
|
GiftCommon Stock | 19,477 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-020902 · doc5.xml · nonDerivative · entry 2 LERNER RICHARD A · CIK 0001316274 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 73,877 F1 · ownership.nature: Securites held by the Lerner Family Trust, Richard A & Nicola G Lerner Trustees U/A Dated 11/14/1994. Read SEC document |
| January 16, 2014 Filed Mar 15, 2017 22:30 UTC |
LERNER RICHARD ADirector
|
GiftCommon Stock | 19,477 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-020902 · doc5.xml · nonDerivative · entry 1 LERNER RICHARD A · CIK 0001316274 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,000 Read SEC document |
| July 30, 2012 Filed Feb 5, 2019 21:31 UTC |
HSIAO JANE PH DDirector · Vice Chairman & CTO
|
PurchaseCommon Stock | 30,000 | $4.35 | $130,500.00 |
DisclosureSEC source: 0001209191-19-007347 · doc4.xml · nonDerivative · entry 4 HSIAO JANE PH D · CIK 0001188834 · Director · Vice Chairman & CTO 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 4,727,404 F1 · ownership.nature: The securities are owned directly by Hsu Gamma Investment, L.P. Dr. Hsiao is the general partner of Hsu Gamma Investment, L.P. The reporting person disclaims beneficial ownership of these securities, except to the extent of any pecuniary interest therein and this report shall not be deemed an admission that the reporting person is the beneficial owner of the securities for purposes of Section 16 or for any other purpose. Read SEC document |
| July 27, 2012 Filed Feb 5, 2019 21:31 UTC |
HSIAO JANE PH DDirector · Vice Chairman & CTO
|
PurchaseCommon Stock | 20,000 | $4.30 | $86,000.00 |
DisclosureSEC source: 0001209191-19-007347 · doc4.xml · nonDerivative · entry 3 HSIAO JANE PH D · CIK 0001188834 · Director · Vice Chairman & CTO 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 4,697,404 F1 · ownership.nature: The securities are owned directly by Hsu Gamma Investment, L.P. Dr. Hsiao is the general partner of Hsu Gamma Investment, L.P. The reporting person disclaims beneficial ownership of these securities, except to the extent of any pecuniary interest therein and this report shall not be deemed an admission that the reporting person is the beneficial owner of the securities for purposes of Section 16 or for any other purpose. Read SEC document |
| May 16, 2012 Filed Mar 15, 2017 22:29 UTC |
LERNER RICHARD ADirector
|
GiftCommon Stock | 54,400 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-020901 · doc5.xml · nonDerivative · entry 2 LERNER RICHARD A · CIK 0001316274 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 54,400 F1 · ownership.nature: Securites held by the Lerner Family Trust, Richard A & Nicola G Lerner Trustees U/A Dated 11/14/1994. Read SEC document |
| May 16, 2012 Filed Mar 15, 2017 22:29 UTC |
LERNER RICHARD ADirector
|
GiftCommon Stock | 54,400 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-020901 · doc5.xml · nonDerivative · entry 1 LERNER RICHARD A · CIK 0001316274 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,000 Read SEC document |
| December 21, 2011 Filed Feb 5, 2019 21:31 UTC |
HSIAO JANE PH DDirector · Vice Chairman & CTO
|
GiftCommon Stock | 831,052 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-007347 · doc4.xml · nonDerivative · entry 1 HSIAO JANE PH D · CIK 0001188834 · Director · Vice Chairman & CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,455,147 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.